| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,901 |
17,933 |
$1.40M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,183 |
8,170 |
$864K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
46,255 |
27,243 |
$779K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,052 |
10,095 |
$683K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,378 |
5,579 |
$577K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,676 |
5,016 |
$304K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,762 |
3,289 |
$261K |
| 36415 |
Collection of venous blood by venipuncture |
30,270 |
19,248 |
$214K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,212 |
7,151 |
$192K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,699 |
1,925 |
$148K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,797 |
1,527 |
$140K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,700 |
1,309 |
$121K |
| 80053 |
Comprehensive metabolic panel |
23,134 |
15,651 |
$119K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,400 |
1,335 |
$117K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,651 |
4,076 |
$115K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,408 |
4,786 |
$111K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,135 |
7,929 |
$106K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,748 |
5,857 |
$87K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,698 |
1,218 |
$84K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,026 |
952 |
$82K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
824 |
776 |
$67K |
| A9270 |
Non-covered item or service |
25,527 |
4,127 |
$60K |
| G0378 |
Hospital observation service, per hour |
5,741 |
1,752 |
$53K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,137 |
889 |
$51K |
| 11043 |
|
505 |
220 |
$51K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,340 |
867 |
$40K |
| 86900 |
|
2,869 |
2,139 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,831 |
19,939 |
$38K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
430 |
360 |
$35K |
| 99215 |
Prolong outpt/office vis |
528 |
461 |
$34K |
| 87015 |
|
1,337 |
976 |
$33K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,974 |
6,957 |
$32K |
| 81025 |
|
3,680 |
3,131 |
$31K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
624 |
563 |
$31K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,921 |
5,400 |
$31K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,037 |
1,210 |
$30K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
238 |
154 |
$30K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
520 |
400 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
2,465 |
1,764 |
$27K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
704 |
629 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
466 |
421 |
$25K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
275 |
205 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,521 |
4,053 |
$21K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,090 |
1,006 |
$20K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,064 |
1,163 |
$19K |
| 81001 |
|
11,634 |
9,157 |
$18K |
| 81003 |
|
4,482 |
3,458 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
9,686 |
7,072 |
$17K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
182 |
147 |
$16K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
418 |
166 |
$16K |
| 87631 |
|
619 |
468 |
$14K |
| 76641 |
|
284 |
224 |
$14K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,465 |
10,880 |
$14K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
4,850 |
2,323 |
$14K |
| 87077 |
|
2,747 |
2,132 |
$12K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,011 |
5,139 |
$11K |
| 76801 |
|
548 |
455 |
$11K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
858 |
725 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,493 |
2,256 |
$10K |
| 76830 |
Ultrasound, transvaginal |
426 |
382 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,739 |
1,470 |
$9K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
20 |
20 |
$8K |
| 97161 |
|
818 |
570 |
$8K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,171 |
455 |
$7K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
108 |
104 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
367 |
284 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,619 |
1,210 |
$7K |
| 87070 |
|
1,805 |
1,406 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
757 |
635 |
$6K |
| 85610 |
|
5,478 |
3,697 |
$6K |
| 87186 |
|
2,209 |
1,688 |
$6K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
684 |
532 |
$6K |
| 20610 |
|
853 |
520 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
150 |
101 |
$5K |
| 81513 |
|
214 |
185 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,014 |
1,171 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,119 |
240 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,518 |
1,015 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,248 |
1,568 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
352 |
301 |
$5K |
| 73030 |
|
722 |
525 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
378 |
109 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
2,614 |
1,551 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
442 |
369 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
669 |
606 |
$4K |
| 85730 |
|
4,135 |
2,903 |
$4K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
152 |
126 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,286 |
2,128 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
684 |
571 |
$4K |
| 73630 |
|
442 |
352 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
529 |
485 |
$4K |
| 90698 |
|
154 |
127 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
738 |
335 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,041 |
3,305 |
$3K |
| 99499 |
|
36 |
34 |
$3K |
| 73610 |
|
186 |
145 |
$3K |
| 87799 |
|
99 |
40 |
$3K |
| J1644 |
Injection, heparin sodium, per 1000 units |
240 |
104 |
$3K |
| 0002A |
|
404 |
329 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
25 |
24 |
$3K |
| 86850 |
|
1,914 |
1,381 |
$3K |
| 84484 |
|
5,620 |
3,365 |
$3K |
| 0001A |
|
415 |
331 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,414 |
3,370 |
$3K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
174 |
143 |
$3K |
| 90647 |
|
81 |
65 |
$3K |
| 90670 |
|
393 |
266 |
$3K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
438 |
280 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
725 |
317 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,481 |
2,783 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
1,892 |
1,232 |
$2K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
19 |
13 |
$2K |
| 80061 |
Lipid panel |
4,339 |
3,521 |
$2K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
141 |
110 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,201 |
2,469 |
$2K |
| 88142 |
|
698 |
649 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
54 |
45 |
$2K |
| 84702 |
|
1,891 |
1,416 |
$2K |
| 87205 |
|
1,249 |
920 |
$2K |
| 87040 |
|
2,235 |
1,050 |
$2K |
| 87210 |
|
490 |
417 |
$2K |
| 87634 |
|
246 |
238 |
$2K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
225 |
122 |
$2K |
| 94060 |
|
33 |
27 |
$2K |
| 83735 |
|
6,309 |
3,727 |
$2K |
| 87088 |
|
2,012 |
1,581 |
$2K |
| 90686 |
|
357 |
107 |
$2K |
| 97162 |
|
103 |
63 |
$2K |
| 86901 |
|
2,869 |
2,135 |
$2K |
| 73564 |
|
110 |
87 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,760 |
2,907 |
$2K |
| 73502 |
|
311 |
216 |
$2K |
| 99205 |
Prolong outpt/office vis |
29 |
25 |
$1K |
| 90633 |
|
130 |
104 |
$1K |
| C1769 |
Guide wire |
221 |
140 |
$1K |
| 93971 |
|
139 |
104 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,803 |
1,647 |
$1K |
| 82728 |
|
921 |
682 |
$1K |
| 82550 |
|
373 |
256 |
$1K |
| 87481 |
|
415 |
296 |
$1K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
163 |
53 |
$1K |
| Q0166 |
Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen |
386 |
156 |
$1K |
| 73562 |
|
162 |
121 |
$1K |
| 36416 |
|
384 |
295 |
$1K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
67 |
41 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,406 |
3,430 |
$1K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
30 |
25 |
$1K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
22 |
12 |
$992.20 |
| 82607 |
|
1,143 |
865 |
$979.51 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
47 |
39 |
$922.20 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
801 |
447 |
$888.08 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
784 |
224 |
$880.49 |
| 83690 |
|
4,261 |
3,250 |
$880.23 |
| 90715 |
|
246 |
184 |
$878.18 |
| 72170 |
|
240 |
164 |
$841.33 |
| 87522 |
Neg quan hep c or qual rna |
54 |
47 |
$813.26 |
| 84439 |
|
1,066 |
835 |
$810.76 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,347 |
928 |
$810.23 |
| 85027 |
|
1,904 |
1,334 |
$769.29 |
| 77080 |
|
91 |
65 |
$768.83 |
| 90680 |
|
149 |
127 |
$765.91 |
| 86140 |
|
881 |
617 |
$734.59 |
| 59025 |
Fetal non-stress test |
390 |
302 |
$719.98 |
| 73130 |
|
163 |
143 |
$704.56 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
34 |
26 |
$652.72 |
| 84100 |
|
2,486 |
1,294 |
$646.97 |
| 83605 |
|
1,932 |
1,278 |
$608.55 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
97 |
93 |
$599.73 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
38 |
24 |
$585.41 |
| 84703 |
|
96 |
80 |
$558.20 |
| 72100 |
|
117 |
80 |
$550.85 |
| 82105 |
|
120 |
106 |
$528.68 |
| 90685 |
|
71 |
28 |
$514.35 |
| 84466 |
|
824 |
639 |
$458.06 |
| 82043 |
|
574 |
468 |
$455.96 |
| 80184 |
|
423 |
326 |
$451.82 |
| 99000 |
|
75 |
50 |
$426.35 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
825 |
431 |
$421.53 |
| 96417 |
|
84 |
52 |
$419.19 |
| 90734 |
|
26 |
12 |
$410.27 |
| 83540 |
|
920 |
708 |
$408.13 |
| J2060 |
Injection, lorazepam, 2 mg |
636 |
430 |
$407.91 |
| 82570 |
|
927 |
721 |
$406.91 |
| 90696 |
|
34 |
14 |
$397.35 |
| 87075 |
|
221 |
169 |
$384.38 |
| 83880 |
|
952 |
703 |
$370.48 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
269 |
248 |
$348.28 |
| 71250 |
|
20 |
13 |
$337.20 |
| 97116 |
|
105 |
41 |
$327.46 |
| 80076 |
|
1,228 |
988 |
$303.29 |
| 82746 |
|
451 |
343 |
$297.33 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
100 |
89 |
$291.22 |
| 85652 |
|
810 |
599 |
$270.11 |
| 90744 |
|
104 |
38 |
$269.19 |
| 86592 |
|
685 |
626 |
$261.23 |
| 90723 |
|
19 |
13 |
$254.88 |
| 86762 |
|
85 |
80 |
$236.82 |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
22 |
13 |
$201.55 |
| 90474 |
|
210 |
175 |
$197.92 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
207 |
176 |
$195.20 |
| 97535 |
Self-care/home management training, each 15 minutes |
82 |
38 |
$184.96 |
| 93017 |
|
14 |
14 |
$182.02 |
| 84153 |
|
142 |
109 |
$181.56 |
| 93296 |
|
39 |
28 |
$174.75 |
| 82805 |
|
23 |
12 |
$171.49 |
| 74018 |
|
13 |
13 |
$166.71 |
| 90710 |
|
45 |
28 |
$160.20 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
191 |
172 |
$148.30 |
| 97165 |
|
156 |
91 |
$147.54 |
| 87340 |
|
518 |
467 |
$140.17 |
| 86803 |
|
660 |
586 |
$127.71 |
| 90756 |
|
138 |
86 |
$123.66 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
667 |
369 |
$111.94 |
| 90688 |
|
80 |
48 |
$109.83 |
| 85007 |
|
300 |
220 |
$108.62 |
| 83970 |
|
141 |
98 |
$107.70 |
| 82272 |
|
40 |
26 |
$87.89 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
744 |
573 |
$86.56 |
| 46600 |
|
13 |
12 |
$68.28 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
32 |
26 |
$62.75 |
| 87512 |
|
46 |
42 |
$61.81 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
17 |
14 |
$60.65 |
| 80050 |
General health panel |
33 |
33 |
$58.74 |
| 83615 |
|
39 |
25 |
$56.58 |
| 84403 |
|
14 |
13 |
$36.84 |
| 94729 |
|
33 |
27 |
$33.43 |
| 94726 |
|
35 |
28 |
$32.86 |
| 0012A |
|
158 |
108 |
$32.51 |
| 88342 |
|
78 |
63 |
$25.95 |
| 85379 |
|
28 |
24 |
$23.34 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
52 |
37 |
$22.23 |
| 82950 |
|
128 |
121 |
$15.75 |
| 84550 |
|
106 |
79 |
$15.52 |
| 86780 |
|
35 |
33 |
$12.65 |
| 84146 |
|
29 |
25 |
$11.52 |
| 81000 |
|
49 |
34 |
$11.31 |
| 82248 |
|
91 |
54 |
$9.39 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
630 |
255 |
$8.81 |
| 80375 |
|
65 |
54 |
$7.79 |
| 82610 |
|
21 |
12 |
$6.62 |
| 51798 |
|
19 |
14 |
$5.35 |
| 86360 |
|
22 |
14 |
$4.44 |
| 0011A |
|
158 |
107 |
$4.08 |
| 87046 |
|
24 |
20 |
$2.59 |
| 87045 |
|
24 |
20 |
$2.59 |
| 96376 |
|
914 |
628 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
466 |
320 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
38 |
25 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
12 |
12 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
30 |
24 |
$0.00 |
| 86704 |
|
20 |
14 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
46 |
33 |
$0.00 |
| 90674 |
|
14 |
12 |
$0.00 |
| 86593 |
|
34 |
32 |
$0.00 |
| 86317 |
|
23 |
17 |
$0.00 |
| 87536 |
|
22 |
14 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
19 |
12 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
20 |
12 |
$0.00 |
| 82378 |
|
40 |
24 |
$0.00 |
| 87905 |
|
301 |
271 |
$0.00 |
| 0003A |
|
61 |
53 |
$0.00 |
| 81329 |
|
20 |
20 |
$0.00 |
| 99001 |
|
14 |
12 |
$0.00 |
| 81243 |
|
20 |
20 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
98 |
78 |
$0.00 |
| 83020 |
|
59 |
55 |
$0.00 |
| 73110 |
|
101 |
65 |
$0.00 |
| 83721 |
|
20 |
14 |
$0.00 |
| 99152 |
|
21 |
13 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
28 |
25 |
$0.00 |
| 77066 |
Tomosynthesis, mammo |
19 |
15 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14 |
12 |
$0.00 |